Laryngeal and hypopharyngeal carcinomas after (chemo)radiotherapy: a diagnostic dilemma.

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44

18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen. Neuroradiology (2009) 0.98

Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol (2012) 0.90

Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol (2012) 0.87

Transoral laser surgery for recurrent glottic cancer after radiotherapy: oncologic and functional outcomes. Acta Otorhinolaryngol Ital (2012) 0.86

Diffusion-weighted MRI in head and neck radiology: applications in oncology. Cancer Imaging (2011) 0.86

High b-Value Diffusion MRI to Differentiate Recurrent Tumors from Posttreatment Changes in Head and Neck Squamous Cell Carcinoma: A Single Center Prospective Study. Biomed Res Int (2016) 0.75

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44

Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol (2011) 3.44

Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer (2012) 2.15

Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol (2013) 1.77

Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol (2010) 1.76

Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg (2006) 1.69

Long-term outcome of ileal conduit diversion. J Urol (2003) 1.50

Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol (2009) 1.07

Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology (2013) 1.07

Alternate or additional findings to stone disease on unenhanced computerized tomography for acute flank pain can impact management. J Urol (2006) 1.06

Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Eur Urol (2011) 1.02

Leg ischemia: assessment with MR angiography and spectroscopy. Radiology (2005) 0.97

Cancer of the oral cavity and oropharynx. Cancer Imaging (2010) 0.93

MR imaging pelvimetry: a useful adjunct in the treatment of women at risk for dystocia? AJR Am J Roentgenol (2002) 0.91

Left atrial metastasis of Hürthle-cell thyroid carcinoma mimicking myxoma. J Nucl Cardiol (2014) 0.90

Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol (2012) 0.90

Therapy response with diffusion MRI: an update. Cancer Imaging (2012) 0.87

Pretherapeutic staging of recurrent laryngeal carcinoma: clinical findings and imaging studies compared with histopathology. Otolaryngol Head Neck Surg (2007) 0.84

Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience. Eur Urol (2011) 0.83

Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site. BJU Int (2012) 0.83

Living renal allograft transplantation: diffusion-weighted MR imaging in longitudinal follow-up of the donated and the remaining kidney. Radiology (2013) 0.83

Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes? Contrast Media Mol Imaging (2012) 0.82

Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents. Eur Radiol (2009) 0.80

Renal and perfusion imaging at 3 T. Top Magn Reson Imaging (2010) 0.80

Functional imaging of the parotid glands using blood oxygenation level dependent (BOLD)-MRI at 1.5T and 3T. J Magn Reson Imaging (2008) 0.78

Three-year follow-up of human transplanted kidneys by diffusion-weighted MRI and blood oxygenation level-dependent imaging. J Magn Reson Imaging (2011) 0.78

Laryngeal involvement by differentiated thyroid carcinoma. Am J Surg (2005) 0.78

Detection of urinary stones at reduced radiation exposure: a phantom study comparing computed radiography and a low-dose digital radiography linear slit scanning system. AJR Am J Roentgenol (2009) 0.77

Comparison of physiological triggering schemes for diffusion-weighted magnetic resonance imaging in kidneys. J Magn Reson Imaging (2010) 0.76

Response to the letter to the editor from Ansje S. Fortuin and Jelle O. Barentsz--Harriet C. Thoeny for the authors. Eur J Cancer (2013) 0.75

FDG uptake in metastatic spreading mucoepidermoid carcinoma of the thyroid. Clin Nucl Med (2007) 0.75

18F-FDG PET/CT of Papillary Carcinoma in a Lateral Thyroglossal Duct Cyst. Clin Nucl Med (2017) 0.75